Decoy Therapeutics (DCOY) Other Working Capital Changes (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Other Working Capital Changes of -$541701.0 for Q1 2020, up 17.38% year-over-year from -$461503.1 in Q2 2019, and up 47.85% quarter-over-quarter from -$1.0 million in Q4 2019.
Decoy Therapeutics (DCOY) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Other Working Capital Changes for 4 consecutive years, with -$541701.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Other Working Capital Changes rose 17.38% year-over-year to -$541701.0; the TTM figure through Dec 2020 stood at -$541701.0 (up 84.37% YoY), while the FY2020 annual figure was -$541701.0, up 84.37% from the prior year.
- Other Working Capital Changes grew to -$541701.0 in Q1 2020 per DCOY's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $763362.0 in Q3 2022 and bottomed at -$921852.0 in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$97681.5 across 5 years, with a median of -$135922.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 407781.42% in 2018 and fell as far as 6820.98% in 2018.
- Decoy Therapeutics' Other Working Capital Changes stood at -$9227.0 in 2017, then plunged by 6820.98% to -$638599.0 in 2018, then slumped by 62.65% to -$1.0 million in 2019, then soared by 47.85% to -$541701.0 in 2020.
- Business Quant data shows DCOY's Other Working Capital Changes at -$541701.0 in Q1 2020, -$1.0 million in Q4 2019, and -$874949.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,026.00 |
| Jun 30, 2026 | 11,026.00 |
| Jun 30, 2026 | 11,026.00 |
| Mar 31, 2026 | 261,821.00 |
| Mar 31, 2026 | 261,821.00 |
| Mar 31, 2026 | 261,821.00 |
| Dec 31, 2025 | -921,852.00 |
| Dec 31, 2025 | -921,852.00 |
| Dec 31, 2025 | -921,852.00 |
| Sep 30, 2025 | 490,565.00 |
| Sep 30, 2025 | 490,565.00 |
| Sep 30, 2025 | 490,565.00 |
| Jun 30, 2025 | 57,987.00 |
| Jun 30, 2025 | 57,987.00 |
| Jun 30, 2025 | 57,987.00 |
| Mar 31, 2025 | -46,328.00 |
| Mar 31, 2025 | -46,328.00 |
| Mar 31, 2025 | -46,328.00 |
| Dec 31, 2024 | 14,417.00 |
| Dec 31, 2024 | 14,417.00 |